Monitoring system
Latest Bayer HealthCare LLC Patents:
- Materials and methods for treatment of usher syndrome type 2A and/or non-syndromic autosomal recessive retinitis pigmentosa (ARRP)
- Viral inactivation methods for continuous manufacturing of antibodies
- Identification tag reader system
- System for conducting a fluid injection procedure
- System and method for syringe plunger engagement with an injector
Description
The broken lines shown in
Claims
The ornamental design for a monitoring system, as shown and described.
Referenced Cited
U.S. Patent Documents
D423102 | April 18, 2000 | Mertenat |
D473310 | April 15, 2003 | Schlagheck et al. |
D528933 | September 26, 2006 | Hunter et al. |
D546456 | July 10, 2007 | May |
D549343 | August 21, 2007 | Schlagheck et al. |
D555021 | November 13, 2007 | Rounds et al. |
D585135 | January 20, 2009 | Mori et al. |
D608892 | January 26, 2010 | Takano et al. |
D625736 | October 19, 2010 | Guarino |
7912655 | March 22, 2011 | Power et al. |
20060259676 | November 16, 2006 | Oberding et al. |
20100319436 | December 23, 2010 | Sun et al. |
Patent History
Patent number: D723694
Type: Grant
Filed: Dec 19, 2013
Date of Patent: Mar 3, 2015
Assignee: Bayer HealthCare LLC (Whippany, NJ)
Inventors: Eugene Prais (West Milford, NJ), Raymond Yao (Ossining, NY), Michael A. Botta (Manorville, NY), Jan Seyberth (Frankfurt Am Main)
Primary Examiner: Anhdao Doan
Application Number: 29/477,045
Type: Grant
Filed: Dec 19, 2013
Date of Patent: Mar 3, 2015
Assignee: Bayer HealthCare LLC (Whippany, NJ)
Inventors: Eugene Prais (West Milford, NJ), Raymond Yao (Ossining, NY), Michael A. Botta (Manorville, NY), Jan Seyberth (Frankfurt Am Main)
Primary Examiner: Anhdao Doan
Application Number: 29/477,045
Classifications
Current U.S. Class:
Hematological Or Intravenous Treatment (41) (D24/169)